Medical College of Wisconsin
CTSIResearch InformaticsREDCap

The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications. J Cardiothorac Vasc Anesth 2022 May;36(5):1467-1476

Date

05/21/2021

Pubmed ID

34011447

DOI

10.1053/j.jvca.2021.04.013

Scopus ID

2-s2.0-85106215254 (requires institutional sign-in at Scopus site)   8 Citations

Abstract

Valvular heart disease contributes to a large burden of morbidity and mortality in the United States. During the last decade there has been a paradigm shift in the management of valve disease, primarily driven by the emergence of novel transcatheter technologies. In this article, the latest update of the American College of Cardiology/American Heart Association valve heart disease guidelines is reviewed.

Author List

Mohananey D, Aljadah M, Smith AAH, Haines JF, Patel S, Villablanca P, Ramakrishna H

Authors

Michael M. Aljadah MD Instructor in the Medicine department at Medical College of Wisconsin
Divyanshu Mohananey MBBS Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

American Heart Association
Cardiology
Heart Valve Diseases
Humans
United States